Clearance of an immunosuppressive virus from the CNS coincides with immune reanimation and diversification

Virology Journal

Volumn 4, Issue , 2007, Pages

  Lauterbach, Henning ^a   Truong, Phi ^a   McGavern, Dorian B ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNE DEFICIENCY; INOCULATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PARENCHYMA; T LYMPHOCYTE; VIRUS EXAMINATION; ANIMAL; B LYMPHOCYTE; BLOOD; C57BL MOUSE; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; DISEASE MODEL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; NERVE CELL; OLFACTORY BULB; OLFACTORY NERVE; PATHOLOGY; SPLEEN; T LYMPHOCYTE SUBPOPULATION; TIME; VIREMIA; VIROLOGY; VIRUS INFECTION;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUS;

ANIMALS; ARENAVIRIDAE INFECTIONS; B-LYMPHOCYTES; BLOOD; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; IMMUNE TOLERANCE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; NEURONS; OLFACTORY BULB; OLFACTORY NERVE; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; VIREMIA;

EID: 34347348127     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-4-53     Document Type: Article

References (62)

1. Viral infections in the developing and mature brain. AN van den Pol, Trends Neurosci 2006 29 7 398 406 10.1016/j.tins.2006.06.002 16806513
2. T-cell-mediated immunopathology in viral infections. PC Doherty RM Zinkernagel, Transplant Rev 1974 19 0 89 120 4601807
3. T cells in the central nervous system: the delicate balance between viral clearance and disease. DB McGavern D Homann MB Oldstone, J Infect Dis 2002 186 Suppl 2 S145 51 10.1086/344264 12424690
4. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. D Kagi B Ledermann K Burki RM Zinkernagel H Hengartner, Ann Rev Immunol 1996 14 207 232 10.1146/annurev.immunol.14.1.207
5. What is the blood-brain barrier (not)? I Bechmann I Galea VH Perry, Trends Immunol 2007 28 1 5 11 10.1016/j.it.2006.11.007 17140851
6. What is immune privilege (not)? I Galea I Bechmann VH Perry, Trends Immunol 2007 28 1 12 8 10.1016/j.it.2006.11.004 17129764
7. Lymphocytic choriomeningitis virus: reemerging central nervous system pathogen. LL Barton NJ Hyndman, Pediatrics 2000 105 3 E35 10.1542/peds.105.3.e35 10699137
8. High resolution in situ hybridization to determine the cellular distribution of lymphocytic choriomeningitis virus RNA in the tissues of persistently infected mice: relevance to arenavirus disease and mechanisms of viral persistence. JK Fazakerley P Southern F Bloom MJ Buchmeier, J Gen Virol 1991 72 Pt 7 1611 25 1649899
9. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. WP Fung-Leung TM Kundig RM Zinkernagel TW Mak, J Exp Med 1991 174 6 1425 9 10.1084/jem.174.6.1425 1683893
10. Molecular basis of organ-specific selection of viral variants during chronic infection. R Ahmed CS Hahn T Somasundaram L Villarete M Matloubian JH Strauss, J Virol 1991 65 8 4242 7 2072451
11. Organ-specific selection of viral variants during chronic infection. R Ahmed MB Oldstone, J Exp Med 1988 167 5 1719 24 10.1084/jem.167.5.1719 3367096
12. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. R Ahmed A Salmi LD Butler JM Chiller MB Oldstone, J Exp Med 1984 160 2 521 40 10.1084/jem.160.2.521 6332167
13. Virus-induced immunosuppression: kinetic analysis of the selection of a mutation associated with viral persistence. CF Evans P Borrow JC de la Torre MB Oldstone, J Virol 1994 68 11 7367 73 7933120
14. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. M Matloubian SR Kolhekar T Somasundaram R Ahmed, J Virol 1993 67 12 7340 9 7693969
15. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. N Sevilla S Kunz A Holz H Lewicki D Homann H Yamada KP Campbell JC de La Torre MB Oldstone, J Exp Med 2000 192 9 1249 60 10.1084/jem.192.9.1249 11067874
16. Tissue-mediated selection of viral variants: correlation between glycoprotein mutation and growth in neuronal cells. L Villarete T Somasundaram R Ahmed, J Virol 1994 68 11 7490 6 7933132
17. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. D Moskophidis F Lechner H Pircher RM Zinkernagel, Nature 1993 362 6422 758 61 10.1038/362758a0 8469287
18. Viral immune evasion due to persistence of activated T cells without effector function. AJ Zajac JN Blattman K Murali-Krishna DJ Sourdive M Suresh JD Altman R Ahmed, J Exp Med 1998 188 12 2205 13 10.1084/jem.188.12.2205 9858507
19. Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. R Ou S Zhou L Huang D Moskophidis, J Virol 2001 75 18 8407 23 11507186 10.1128/JVI.75.18.8407-8423.2001
20. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. EJ Wherry JN Blattman K Murali-Krishna R van der Most R Ahmed, J Virol 2003 77 8 4911 27 12663797 10.1128/JVI.77.8.4911-4927.2003
21. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. DG Brooks L Teyton MB Oldstone DB McGavern, J Virol 2005 79 16 10514 27 16051844 10.1128/JVI.79.16.10514-10527. 2005
22. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. M Salvato P Borrow E Shimomaye MB Oldstone, J Virol 1991 65 4 1863 9 1840619
23. Genetic analysis of in vivo-selected viral variants causing chronic infection: importance of mutation in the L RNA segment of lymphocytic choriomeningitis virus. R Ahmed RS Simon M Matloubian SR Kolhekar PJ Southern DM Freedman, J Virol 1988 62 9 3301 8 3261347
24. Genetic basis of viral persistence: single amino acid change in the viral glycoprotein affects ability of lymphocytic choriomeningitis virus to persist in adult mice. M Matloubian T Somasundaram SR Kolhekar R Selvakumar R Ahmed, J Exp Med 1990 172 4 1043 8 10.1084/jem.172.4.1043 2212940
25. Three or more routes for leukocyte migration into the central nervous system. RM Ransohoff P KivisAkk G Kidd, Nat Rev Immunol 2003 3 7 569 81 10.1038/nri1130 12876559
26. Lymphocytic choriomeningitis: ultrastructural pathology. DH Walker FA Murphy SG Whitfield SP Bauer, Exp Mol Pathol 1975 23 2 245 65 10.1016/0014-4800(75)90022-2 1183539
27. Competitive selection in vivo by a cell for one variant over another: implications for RNA virus quasispecies in vivo. J Dockter CF Evans A Tishon MB Oldstone, J Virol 1996 70 3 1799 803 8627703
28. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. H Pircher K Burki R Lang H Hengartner RM Zinkernagel, Nature 1989 342 6249 559 61 10.1038/342559a0 2573841
29. A novel approach to visualize polyclonal virus-specific CD8 T cells in vivo. C Zimmermann H Pircher, J Immunol 1999 162 9 5178 5182 10227990
30. Molecular anatomy of antigen-specific CD8(+) T cell engagement and synapse formation in vivo. DB McGavern U Christen MB Oldstone, Nat Immunol 2002 3 10 918 25 10.1038/ni843 12352968
31. Rebuilding an immune-mediated central nervous system disease: weighing the pathogenicity of antigen-specific versus bystander T cells. DB McGavern P Truong, J Immunol 2004 173 8 4779 90 15470017
32. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. V Vezys D Masopust CC Kemball DL Barber LA O'Mara CP Larsen TC Pearson R Ahmed AE Lukacher, J Exp Med 2006 203 10 2263 9 10.1084/jem.20060995 16966427
33. Estimating the precursor frequency of naive antigen-specific CD8 T cells. JN Blattman R Antia DJ Sourdive X Wang SM Kaech K Murali-Krishna JD Altman R Ahmed, J Exp Med 2002 195 5 657 64 10.1084/jem.20001021 11877489
34. Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system. S Hawke PG Stevenson S Freeman CR Bangham, J Exp Med 1998 187 10 1575 82 10.1084/jem.187.10.1575 9584136
35. Prolonged presence of effector-memory CD8 T cells in the central nervous system after dengue virus encephalitis. RG van der Most K Murali-Krishna R Ahmed, Int Immunol 2003 15 1 119 25 10.1093/intimm/dxg009 12502732
36. Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. MJ Fuller A Khanolkar AE Tebo AJ Zajac, J Immunol 2004 172 7 4204 14 15034033
37. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. D Homann L Teyton MB Oldstone, Nat Med 2001 7 8 913 9 10.1038/90950 11479623
38. Restoring function in exhausted CD8 T cells during chronic viral infection. DL Barber EJ Wherry D Masopust B Zhu JP Allison AH Sharpe GJ Freeman R Ahmed, Nature 2006 439 7077 682 7 10.1038/nature04444 16382236
39. Interleukin-10 determines viral clearance or persistence in vivo. DG Brooks MJ Trifilo KH Edelmann L Teyton DB McGavern MB Oldstone, Nat Med 2006 12 11 1301 9 10.1038/nm1492 17041596
40. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. CL Day DE Kaufmann P Kiepiela JA Brown ES Moodley S Reddy EW Mackey JD Miller AJ Leslie C DePierres Z Mncube J Duraiswamy B Zhu Q Eichbaum M Altfeld EJ Wherry HM Coovadia PJ Goulder P Klenerman R Ahmed GJ Freeman BD Walker, Nature 2006 443 7109 350 4 10.1038/nature05115 16921384
41. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. C Petrovas JP Casazza JM Brenchley DA Price E Gostick WC Adams ML Precopio T Schacker M Roederer DC Douek RA Koup, J Exp Med 2006 203 10 2281 92 10.1084/jem.20061496 16954372
42. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. L Trautmann L Janbazian N Chomont EA Said S Gimmig B Bessette MR Boulassel E Delwart H Sepulveda RS Balderas JP Routy EK Haddad RP Sekaly, Nat Med 2006 12 10 1198 202 10.1038/nm1482 16917489
43. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. EJ Wherry DL Barber SM Kaech JN Blattman R Ahmed, Proc Natl Acad Sci USA 2004 101 45 16004 9 15505208 10.1073/pnas.0407192101
44. Astrocyte-endothelial interactions at the blood-brain barrier. NJ Abbott L Ronnback E Hansson, Nat Rev Neurosci 2006 7 1 41 53 10.1038/nrn1824 16371949
45. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. W Cao MD Henry P Borrow H Yamada JH Elder EV Ravkov ST Nichol RW Compans KP Campbell MB Oldstone, Science 1998 282 5396 2079 81 10.1126/science.282.5396.2079 9851928
46. Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. M Sixt B Engelhardt F Pausch R Hallmann O Wendler LM Sorokin, J Cell Biol 2001 153 5 933 46 10.1083/jcb.153.5.933 11381080
47. Dystroglycan in the cerebellum is a laminin alpha 2-chain binding protein at the glial-vascular interface and is expressed in Purkinje cells. M Tian C Jacobson SH Gee KP Campbell S Carbonetto M Jucker, Eur J Neurosci 1996 8 12 2739 47 10.1111/j.1460-9568.1996.tb01568.x 8996823
48. Dystroglycan distribution in adult mouse brain: a light and electron microscopy study. ML Zaccaria F Di Tommaso A Brancaccio P Paggi TC Petrucci, Neuroscience 2001 104 2 311 24 10.1016/S0306-4522(01)00092-6 11377836
49. Critical role for glial cells in the propagation and spread of lymphocytic choriomeningitis virus in the developing rat brain. DJ Bonthius J Mahoney MJ Buchmeier B Karacay D Taggard, J Virol 2002 76 13 6618 35 12050375 10.1128/JVI.76.13.6618-6635.2002
50. Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins. H Miletic YH Fischer H Neumann V Hans W Stenzel T Giroglou M Hermann M Deckert D Von Laer, Hum Gene Ther 2004 15 11 1091 100 10.1089/hum.2004.15.1091 15610609
51. Immunotherapy for virus infection. MB Oldstone, Curr Top Microbiol Immunol 1987 134 211 29 3495409
52. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. MB Oldstone P Blount PJ Southern PW Lampert, Nature 1986 321 6067 239 43 10.1038/321239a0 3086743
53. Adoptive immunotherapy induces CNS dendritic cell recruitment and antigen presentation during clearance of a persistent viral infection. H Lauterbach EI Zuniga P Truong MB Oldstone DB McGavern, J Exp Med 2006 203 8 1963 75 10.1084/jem.20060039 16847068
54. The lymphocytic choriomeningitis virus envelope glycoprotein targets lentiviral gene transfer vector to neural progenitors in the murine brain. CS Stein I Martins BL Davidson, Mol Ther 2005 11 3 382 9 10.1016/j.ymthe.2004.11. 008 15727934
55. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. F Doetsch I Caille DA Lim JM Garcia-Verdugo A Alvarez-Buylla, Cell 1999 97 6 703 16 10.1016/S0092-8674(00)80783-7 10380923
56. The glial identity of neural stem cells. F Doetsch, Nat Neurosci 2003 6 11 1127 34 10.1038/nn1144 14583753
57. Challenges for brain repair: insights from adult neurogenesis in birds and mammals. F Doetsch C Scharff, Brain Behav Evol 2001 58 5 306 22 10.1159/000057572 11978948
58. Exhaustion of cytotoxic T cells during adoptive immunotherapy of virus carrier mice can be prevented by B cells or CD4+ T cells. L Hunziker P Klenerman RM Zinkernagel S Ehl, Eur J Immunol 2002 32 2 374 82 10.1002/1521-4141(200202) 32:2<374::AID-IMMU374>3.0.CO;2-9 11813156
59. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. O Planz S Ehl E Furrer E Horvath MA Brundler H Hengartner RM Zinkernagel, Proc Natl Acad Sci USA 1997 94 13 6874 9 9192659 10.1073/pnas.94.13.6874
60. Control of central nervous system viral persistence by neutralizing antibody. C Ramakrishna CC Bergmann R Atkinson SA Stohlman, J Virol 2003 77 8 4670 8 12663773 10.1128/JVI.77.8.4670-4678.2003
61. Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. C Ramakrishna SA Stohlman RD Atkinson MJ Shlomchik CC Bergmann, J Immunol 2002 168 3 1204 11 11801656
62. Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection. JR Baldridge MJ Buchmeier, J Virol 1992 66 7 4252 7 1376367